Loading...
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy
BACKGROUND: The administration of rituximab (RTX) in vivo results in B-cell depletion, but evidence for multiple mechanisms of action have been reported. Surprisingly, B cell depletion produced a response in patients with polymyositis, which is characterized as a T cell-mediated autoimmune disorder...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2912795/ https://ncbi.nlm.nih.gov/pubmed/20618995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-11-157 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|